Variables of prospective response rates of PD-1/PD-L1 based therapies across cancers
August 28, 2019 – Immune checkpoint inhibitor (ICI) therapy is a form of cancer immunotherapy. The therapy targets immune checkpoints, key regulators of the immune system that when stimulated can dampen the immune response to an immunologic stimulus. Some cancers …
Variables of prospective response rates of PD-1/PD-L1 based therapies across cancers Read more »